[HTML][HTML] Suppression of antiviral innate immunity by sunitinib enhances oncolytic virotherapy

BK Jha, B Dong, CT Nguyen, I Polyakova… - Molecular Therapy, 2013 - cell.com
The use of lytic viruses to preferentially infect and eliminate cancer cells while sparing
normal cells is a promising experimental therapeutic approach for treating cancer. However …

[PDF][PDF] Suppression of antiviral innate immunity by sunitinib enhances oncolytic virotherapy

BK Jha, B Dong, I Polyakova, RH Silverman - academia.edu
The use of lytic viruses to preferentially infect and eliminate cancer cells while sparing
normal cells is a promising experimental therapeutic approach for treating cancer. However …

[HTML][HTML] Suppression of Antiviral Innate Immunity by Sunitinib Enhances Oncolytic Virotherapy

BK Jha, B Dong, CT Nguyen, I Polyakova… - Molecular Therapy, 2013 - Elsevier
The use of lytic viruses to preferentially infect and eliminate cancer cells while sparing
normal cells is a promising experimental therapeutic approach for treating cancer. However …

Suppression of antiviral innate immunity by sunitinib enhances oncolytic virotherapy

BK Jha, B Dong, CT Nguyen… - … therapy: the journal …, 2013 - pubmed.ncbi.nlm.nih.gov
The use of lytic viruses to preferentially infect and eliminate cancer cells while sparing
normal cells is a promising experimental therapeutic approach for treating cancer. However …

Suppression of antiviral innate immunity by sunitinib enhances oncolytic virotherapy.

BK Jha, B Dong, CT Nguyen, I Polyakova… - … Therapy: the Journal …, 2013 - europepmc.org
The use of lytic viruses to preferentially infect and eliminate cancer cells while sparing
normal cells is a promising experimental therapeutic approach for treating cancer. However …

[PDF][PDF] Suppression of Antiviral Innate Immunity by Sunitinib Enhances Oncolytic Virotherapy

BK Jha, B Dong, CT Nguyen, I Polyakova… - Molecular …, 2013 - cyberleninka.org
There is a critical need for innovative and novel approaches for the treatment of advanced
metastatic cancer. Oncolytic viruses (OVs) are therapeutically used microbes, either …

Suppression of Antiviral Innate Immunity by Sunitinib Enhances Oncolytic Virotherapy.

BK Jha, B Dong, CT Nguyen, I Polyakova… - Molecular …, 2013 - search.ebscohost.com
The use of lytic viruses to preferentially infect and eliminate cancer cells while sparing
normal cells is a promising experimental therapeutic approach for treating cancer. However …

Suppression of Antiviral Innate Immunity by Sunitinib Enhances Oncolytic Virotherapy

BK Jha, B Dong, CT Nguyen, I Polyakova… - Molecular …, 2013 - search.proquest.com
The use of lytic viruses to preferentially infect and eliminate cancer cells while sparing
normal cells is a promising experimental therapeutic approach for treating cancer. However …

[HTML][HTML] Suppression of Antiviral Innate Immunity by Sunitinib Enhances Oncolytic Virotherapy

BK Jha, B Dong, CT Nguyen, I Polyakova… - Molecular …, 2013 - ncbi.nlm.nih.gov
The use of lytic viruses to preferentially infect and eliminate cancer cells while sparing
normal cells is a promising experimental therapeutic approach for treating cancer. However …

[PDF][PDF] Suppression of antiviral innate immunity by sunitinib enhances oncolytic virotherapy

BK Jha, B Dong, I Polyakova, RH Silverman - academia.edu
The use of lytic viruses to preferentially infect and eliminate cancer cells while sparing
normal cells is a promising experimental therapeutic approach for treating cancer. However …